Skip to main content

Table 3 Sensitivity Analysis 1: Association of risk factors with hazard of ventricular arrhythmias adjusted for specific disease risk factors for ventricular arrhythmias instead of Charlson index

From: Allopurinol and the risk of ventricular arrhythmias in the elderly: a study using US Medicare data

 

Multivariable adjusted (Model 3)

Multivariable adjusted (Model 4)

HR (95% CI)

P value

HR (95% CI)

P value

Allopurinol use

0.82 (0.75–0.89)

< 0.0001

–

–

Allopurinol use durationa

 0 days (non-use)

–

–

Ref

 

 1–180 days

–

–

0.92 (0.82–1.04)

0.18

 181 days to 2 years

–

–

0.76 (0.68–0.84)

< 0.0001

  > 2 years

–

–

0.78 (0.65–0.94)

0.009

  1. aBased on person day count
  2. Model 3 = Allopurinol use + age + race + sex + beta blockers + diuretics + ACE inhibitors + statins + CAD + cardiomyopathy + heart failure + congenital heart disease + valvular heart disease + renal failure + dialysis + sarcoidosis + hyperkalemia
  3. Model 4 = Allopurinol duration + age + race + sex + beta blockers + diuretics + ACE inhibitors + statins + CAD + cardiomyopathy + heart failure + congenital heart disease + valvular heart disease + renal failure + dialysis + sarcoidosis + hyperkalemia
  4. Significant hazards ratios and P values are in bold
  5. HR hazard ratio, CI confidence interval, Ref referent category